Quintiles Acquires Encore Health Resources

Quintiles has announced that it has entered in an agreement to acquire Encore Health Resources, which is a health information and analytics company that provides technology services to healthcare providers. Encore helps its clients through the use of analytics and big data, helping clients through strategy, advisory, implementation, optimization, and performance improvement processes. Quintiles acquired Encore in order to improve the company’s own electronic health records (EHR) capabilities, as EHR expertise is becoming a larger focus for biopharmaceutical clients focused on clinical effectiveness and performance in the market.

Tom Pike, the CEO at Quintiles, says that this acquisition will be an important asset for Quintiles, as it will enable them to provide more services for clients in the biopharmaceutical industry. “Encore has significant EHR expertise, strong relationships with many large U.S. provider networks and academic medical centers as well as experienced consultants, proven tools, and methodologies. It will be a key strategic addition for our business that will extend our services suite and allow us to work with Encore to strengthen its provider-focused solutions,” said Pike. He also says that the acquisition will help the company provide its customers with real-world information that could ‘inform them of their probability of success.’

For Encore, the deal allows the company access to Quintiles vast resources, including the company’s 950 medical doctors, 900 PhDs, and its team of nurse educators and biostatisticians. Dana Sellers, the CEO of Encore, said that the company looks forward to joining a global leader that can help further the quality of Encore’s own analytic services.

Quintiles is the world’s largest biopharmaceutical development and commercial outsourcing company. Quintiles operates in about 100 different countries and has assisted in the development or commercialization of the top-50 best-selling drugs in the market.